Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiki Doi

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
BMC Nephrology|August 30, 2020
A case report of adult-onset COQ8B nephropathy presenting focal segmental glomerulosclerosis with granular swollen podocytesYujiro Maeoka, Toshiki Doi, Masaho Aizawa, et al.
Kidney International|March 15, 2013
Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signalingToshinori Ueno, Ayumu Nakashima, Shigehiro Doi, et al.
Journal of the American Society of Nephrology : JASN|June 6, 2015
Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal FibrosisKensuke Sasaki, Shigehiro Doi, Ayumu Nakashima, et al.
Scientific Reports|January 14, 2021
Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosisRyo Kanai, Ayumu Nakashima, Shigehiro Doi, et al.
The Journal of Vascular Access|December 6, 2023
Early arteriovenous fistula failure associated with mortality and major adverse cardiovascular events in patients undergoing incident hemodialysisAiko Okubo, Toshiki Doi, Yumi Yamada, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 15, 2025
Targeting MLL1/WDR5-Mediated Epigenetic Regulation Mitigates Peritoneal Fibrosis by Reducing p16<sup>INK4a</sup>Daisuke Hara, Kensuke Sasaki, Shigehiro Doi, et al.
Kidney Medicine|December 1, 2025
Temporal and Demographic Trends in Biopsy-Proven Kidney Disease Diagnoses in the Southwestern United States, 1993-2022Akira Takahashi, Daisuke Kiyozawa, Takamasa Miyauchi, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
BMC Nephrology|August 30, 2020
A case report of adult-onset COQ8B nephropathy presenting focal segmental glomerulosclerosis with granular swollen podocytesYujiro Maeoka, Toshiki Doi, Masaho Aizawa, et al.
Kidney International|March 15, 2013
Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signalingToshinori Ueno, Ayumu Nakashima, Shigehiro Doi, et al.
Journal of the American Society of Nephrology : JASN|June 6, 2015
Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal FibrosisKensuke Sasaki, Shigehiro Doi, Ayumu Nakashima, et al.
Scientific Reports|January 14, 2021
Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosisRyo Kanai, Ayumu Nakashima, Shigehiro Doi, et al.
The Journal of Vascular Access|December 6, 2023
Early arteriovenous fistula failure associated with mortality and major adverse cardiovascular events in patients undergoing incident hemodialysisAiko Okubo, Toshiki Doi, Yumi Yamada, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 15, 2025
Targeting MLL1/WDR5-Mediated Epigenetic Regulation Mitigates Peritoneal Fibrosis by Reducing p16<sup>INK4a</sup>Daisuke Hara, Kensuke Sasaki, Shigehiro Doi, et al.
Kidney Medicine|December 1, 2025
Temporal and Demographic Trends in Biopsy-Proven Kidney Disease Diagnoses in the Southwestern United States, 1993-2022Akira Takahashi, Daisuke Kiyozawa, Takamasa Miyauchi, et al.
Pageof 5